7.0T Magnetic Resonance Imaging Study for Hepatic Encephalopathy
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-89
SponsorChinese PLA General Hospital
About this trial
This clinical trial study aims to detect the imaging characteristics of patients with hepatic encephalopathy (HE) using 7-Tesla (7T) magnetic resonance imaging (MRI).
Eligibility criteria
Qualifiers
Patients with clinical suspected or diagnosed hepatic encephalopathy according to relevant guidelines.The patient's education level is above primary school level.
Regular follow-up.
Disqualifiers
Contraindications to MRI.
Patients with cerebrovascular disease, brain tumors, epilepsy, other neurodegenerative disease.
Trial design
Treatments tested in this trial
- 7.0T MRI-Scan
Treatment groups
200 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov